Shandong Longlive Bio-Technology’s poor performance in H1

Summary: Shandong Longlive Bio-Technology published its H1 financials on 30 Aug. – revenues down 59.62% YoY and net loss up 47.34% YoY due to its debt crisis. On 30 Aug., Shandong Longlive Bio-Technology Co., Ltd. (Shandong Longlive Bio-Technol...

Corn Products China News 201909

www.cnchemicals.com